These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7945002)
1. Long-term study with gabapentin in patients with drug-resistant epileptic seizures. Sivenius J; Ylinen A; Kälviäinen R; Riekkinen PJ Arch Neurol; 1994 Oct; 51(10):1047-50. PubMed ID: 7945002 [TBL] [Abstract][Full Text] [Related]
2. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study. Appleton R; Fichtner K; LaMoreaux L; Alexander J; Maton S; Murray G; Garofalo E Dev Med Child Neurol; 2001 Apr; 43(4):269-73. PubMed ID: 11305405 [TBL] [Abstract][Full Text] [Related]
3. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group. Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830 [TBL] [Abstract][Full Text] [Related]
4. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83. Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335 [TBL] [Abstract][Full Text] [Related]
5. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group. Epilepsy Res; 1994 May; 18(1):67-73. PubMed ID: 8088258 [TBL] [Abstract][Full Text] [Related]
7. Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study. Mayer T; Schütte W; Wolf P; Elger CE Acta Neurol Scand; 1999 Jan; 99(1):1-7. PubMed ID: 9925232 [TBL] [Abstract][Full Text] [Related]
8. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group. Anhut H; Ashman P; Feuerstein TJ; Sauermann W; Saunders M; Schmidt B Epilepsia; 1994; 35(4):795-801. PubMed ID: 8082624 [TBL] [Abstract][Full Text] [Related]
9. Double-blind study of Gabapentin in the treatment of partial seizures. Sivenius J; Kälviäinen R; Ylinen A; Riekkinen P Epilepsia; 1991; 32(4):539-42. PubMed ID: 1907907 [TBL] [Abstract][Full Text] [Related]
10. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy. Goa KL; Sorkin EM Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432 [TBL] [Abstract][Full Text] [Related]
11. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy. Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and safety of gabapentin. Ramsay RE Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537 [TBL] [Abstract][Full Text] [Related]